Abbott appoints Claire Babineaux-Fontenot to Board; board size expanded to 13

ABBOTT LABORATORIES

Claire Babineaux-Fontenot named to Abbott's Board of Directors effective September 15, 2022.
Board size increased from 12 to 13 directors via bylaw amendment on same date.
By-laws amended and restated to reflect new board size; Exhibit 3.1 filed.

item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Claire Babineaux-Fontenot

Director

ABT · ABBOTT LABORATORIES

Effective: 2022-09-15
Filed: September 15, 2022, 7:59 PM ET

On September 15, 2022, Claire Babineaux-Fontenot was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Claire Babineaux-Fontenot was named as Director at ABBOTT LABORATORIES.

Action: named
Role: Director

Exact text from the filing

On September 15, 2022, Claire Babineaux-Fontenot was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.

View on SEC.gov

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR

accession 0001104659-22-100434

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.